S'abonner

The influence of pregnancy, parity, and mode of delivery on urinary incontinence and prolapse surgery—a national register study - 22/12/22

Doi : 10.1016/j.ajog.2022.07.035 
Jennie Larsudd-Kåverud, MD a, b, Julia Gyhagen, MD b, Sigvard Åkervall, MD, PhD a, Mattias Molin, BSc a, d, Ian Milsom, MD, PhD e, Adrian Wagg, MD, PhD a, f, Maria Gyhagen, MD, PhD a, c,
a Gothenburg Continence Research Centre, Institute of Clinical Sciences, Sahlgrenska Academy at Gothenburg University, Gothenburg, Sweden 
b Department of Obstetrics and Gynecology, Södra Älvsborgs Hospital, Borås, Sweden 
c Department of Geriatrics, Dalen Hospital, Stockholm, Sweden 
d Statistical Consultancy Group, Gothenburg, Sweden 
e Department of Obstetrics and Gynecology, Sahlgrenska University Hospital, Gothenburg, Sweden 
f Division of Geriatric Medicine, University of Alberta, Edmonton, Alberta, Canada 

Corresponding author: Maria Gyhagen, MD, PhD.

Abstract

Background

The long-term effects of vaginal delivery, parity, and pregnancy on the pelvic floor remain uncertain and controversial issues. In comparison with studies using self-reported symptoms, surgical register data may offer a more valid means for evaluating the relative influence of these risk factors.

Objective

This study used data from 3 high-quality nationwide registers, namely the Swedish National Quality Register of Gynecological Surgery, the Swedish Medical Birth Register, and the Total Population Register, to evaluate the contribution of vaginal and cesarean delivery, parity, and factors not related to childbirth to the long-term risk for reconstructive urogenital surgery.

Study Design

This was a register-based linkage study among women aged ≥45 years who underwent urinary incontinence or prolapse surgery from 2010 to 2017. This surgical cohort was divided into nulliparous women, women with ≥1 cesarean deliveries only, those with ≥1 vaginal deliveries, and according to the number of births. A corresponding reference group was constructed based on women born in 1960 from the Total Population Register (n=2,309,765). The Swedish Medical Birth Register was used to determine the rate of women with cesarean and vaginal delivery and their respective parity. Absolute and relative risk were presented per 1000 women with 95% confidence intervals. Pairwise differences were analyzed with Fisher exact tests and the Mann-Whitney U test for dichotomous and continuous variables. The trend between ≥3 ordered categories of dichotomous variables was analyzed with Mantel-Haenszel statistics.

Results

A total of 39,617 women underwent prolapse surgery and 20,488 underwent incontinence surgery. Among women with prolapse surgery, 97.8% had ≥1 vaginal delivery, 0.4% had ≥1 cesarean delivery only, and 1.9% were nullipara. Corresponding figures for those with incontinence surgery were 93.1%, 2.6%, and 4.3%, respectively. Women with vaginal deliveries were overrepresented in the prolapse surgery (relative risk, 1.23; 95% confidence interval, 1.22–1.24; P<.001) and incontinence surgery groups (relative risk, 1.17; 95% confidence interval, 1.15–1.19; P<.001). Nulliparous and cesarean delivered women were underrepresented in the prolapse surgery (relative risk, 0.14; 95% confidence interval, 0.13–0.15 and relative risk 0.055; 95% confidence interval, 0.046–0.065; all P<.001) and incontinence surgery groups (relative risk, 0.31; 95% confidence interval, 0.29–0.33 and relative risk, 0.40; 95% confidence interval, 0.36–0.43). The absolute risk for prolapse surgery was lowest after cesarean delivery (0.09 per 1000 women; 95% confidence interval, 0.08–0.11) and differed by a factor of 23 (absolute risk, 2.11 per 1000 women; 95% confidence interval, 2.09–2.13) from that after vaginal birth. The absolute risk for prolapse and incontinence surgery increased consistently with parity after vaginal births. This trend was not observed after cesarean delivery, which is on par with that of nulliparous women. The first vaginal birth contributed the highest increase in the absolute risk for pelvic organ prolapse surgery (6-fold) and stress urinary incontinence surgery (3-fold). The second vaginal birth contributed the lowest increase in the absolute risk for pelvic organ prolapse surgery (∼1/3 of the first vaginal birth) and for stress urinary incontinence surgery (∼1/10 of the first vaginal birth).

Conclusion

Surgery for urinary incontinence and prolapse was almost exclusively related to vaginal parity. The risk for prolapse surgery increased consistently with parity after vaginal births but not after cesarean delivery, whereas the risk associated with cesarean delivery was on par with that of nulliparous women. Thus, cesarean delivery seems to offer protection from the need for pelvic organ prolapse and stress urinary incontinence surgery later in life.

Le texte complet de cet article est disponible en PDF.

Key words : cesarean delivery, mode of delivery, pelvic floor disorders, pelvic organ prolapse, stress urinary incontinence, surgical outcomes, vaginal delivery


Plan


 M.G. reports receiving honoraria from Essity Hygiene & Healthcare, Sweden, Essity, and Astellas Pharma. I.M. reports receiving honoraria for lectures from SCA and Essity, Astellas Pharma, Pfizer, Pierre Fabre Laboratories, and Allergan. A.W. reports receiving research support and honoraria as a speaker from Essity, Urovant Sciences, and Pfizer. The remaining authors report no conflict of interest.
 The study was financed by grants from the Swedish state under the agreement between the Swedish Government and the county councils, the ALF-agreement under grant number ALFGBG-966115, Hjalmar Svenssons Fund under grant number HJSV2021017, and the Sparbankstiftelsen Sjuhärad Fund under grant number 20201325. The funding sources had no role in the study design, data analysis, data interpretation, or writing of the report.
 Cite this article as: Larsudd-Kåverud J, Gyhagen J, Åkervall S, et al. The influence of pregnancy, parity, and mode of delivery on urinary incontinence and prolapse surgery––a national register study. Am J Obstet Gynecol 2023;228:61.e1-13.


© 2022  The Author(s). Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 228 - N° 1

P. 61.e1-61.e13 - janvier 2023 Retour au numéro
Article précédent Article précédent
  • Less is more: clinical utility of postoperative laboratory testing following minimally invasive hysterectomy for endometrial cancer
  • Michelle D.S. Lightfoot, Ashley S. Felix, Corinne A. Calo, John T. Hosmer-Quint, Krista L. Taylor, Melissa B. Brown, Ritu Salani, Larry J. Copeland, David M. O’Malley, Kristin L. Bixel, David E. Cohn, Jeffrey M. Fowler, Floor J. Backes, Casey M. Cosgrove
| Article suivant Article suivant
  • Characteristics associated with composite surgical failure over 5 years of women in a randomized trial of sacrospinous hysteropexy with graft vs vaginal hysterectomy with uterosacral ligament suspension
  • Holly E. Richter, Amaanti Sridhar, Charles W. Nager, Yuko M. Komesu, Heidi S. Harvie, Halina M. Zyczynski, Charles Rardin, Anthony Visco, Donna Mazloomdoost, Sonia Thomas, Eunice Kennedy Shriver National Institute of Child Health and Human Development Pelvic Floor Disorders Network

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.